Our studies focus on bacteria of the human microbiome including Campylobacter and Helicobacter species that live in the mucus layer overlying the mucosal epithelium of mammals, including humans. Specifically, we explore the biology of colonization and the nature of the interactions that lead to (or protect from) disease. For the normal microbiome, we study how early life perturbations affect host developmental phenotypes. Our on-going work focuses on the metabolic syndrome, and specifically on obesity and type 2 diabetes, as well as inflammatory disorders such as type 1 diabetes, asthma, psoriasis, and skin infections.
Muriel G. and George W. Singer Professor of Translational Medicine, Department of Medicine
Professor, Department of Microbiology
Director Human Microbiome Program
MD from New York University
Nephrology, dialysis, transplantation. 2017 Nov 1; 32(11):1809-1817
American journal of gastroenterology. 2017 Oct 31; ?-?
International journal of systematic & evolutionary microbiology. 2017 Oct; 67(10):4289-4289
Nature communications. 2017 Sep 11; 8(1):518-518
Effect of single early-in-life antibiotic course on microbial community structure and susceptibility to DSS-induced colitis [Meeting Abstract]
Helicobacter. 2017 September; Conference:(30th):123
PLoS one. 2017 Aug 30; 12(8):e0184046-e0184046e0184046
Microbiome. 2017 Aug 25; 5(1):108-108
Nature reviews. Immunology. 2017 Jul 27; 17(8):461-463